SAN DIEGO, April 10, 2007 – End2End Integration is pleased to announce the launch of Gilead Science's 2006 Annual Report Site (www.gilead.com/AR2006/).

In 2006, Gilead experienced rapid growth and continued commercial success of their products. To continue an expressive dialog with their investors, Gilead turned to End2End to design and develop their 2006 Annual Report web site. The new site effectively communicates their successful efforts, achievements, and future direction of the company..

Providing on online experience for their investors and the public, Gilead continues to explore new and better ways to promote their focus on the development and delivery of medications that advance the treatment of life-threatening diseases worldwide.

About Gilead

Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. The company's mission is to advance the care of patients suffering from life-threatening diseases worldwide. Headquartered in Foster City, California, Gilead has operations in North America, Europe and Australia.

For more information on Gilead Sciences, please visit www.gilead.com or call the Gilead Public Affairs Department at 1-800-GILEAD-5 (1-800-445-3235).

CONTACT: Gilead Sciences, Inc.
Susan Hubbard, 650-522-5715
Investor Relations
SOURCE: Gilead Sciences, Inc.

About End2End Integration

End2End is a strategic design and consulting organization that develops effective websites, powerful web applications, and successful branding solutions. Since 2001, End2End has employed a multi-disciplinary strategic culture that unites the most effective elements of research, design, and technology. End2End’s user-centric methodology empowers business process, promotes competitive advantage, and maximizes returns on internet based initiatives. For more information, please visit www.e2ei.com

###